IL-1 activates downstream pathways including NF-kB which increases the migratory activity of breast cancer cells, and in turn upregulates CXCL8 under oxygen deprivation (Naldini et al., 2010; Filippi et al., 2015; Storr et al., 2017). Here, IL1B is linked to breast cancer.